(Report) 45th Breakfast Meeting
date : 9/19/2013
In May 2013, as a result of how the Hollywood actress Angelina Jolie had boldly shared her experience which she explained of how and why she had underwent mastectomy to prevent the risk of developing breast cancer in the future when she found that mutations in the BRCA1 gene were detected in the genetic testing of hereditary breast ovarian cancer via New York Times The Opinion Pages, the news had turned into a hot topic in Japan.
At almost the same time, “New prenatal diagnosis” was available for the pregnant women to determine the presence of chromosomal abnormalities in fetal blood test in April this year. As the genetic analysis technology advances, examining and predicting future disease of the baby through fetal genetic testing is made possible. However, this has also accompanied with difficult choices to make. Fear is also voiced as the technology may lead to discrimination of people with possible diseases.
We invited Chieko Tamura, the only person in Japan who holds both American and Japanese certificates as a genetic counselor to share with us the current situation and challenges of genetic counseling and genetic testing.
(medium: Japanese)
■Theme
“Why
did Angelina Jolie undergo the surgery? – a perspective of a certified
genetic counselor from both Japan and the United States with regards to
the current situation and challenges of genetic counseling and genetic
testing.”
■Speaker
Chieko Tamura
Chieko Tamura originally studied pharmaceutical science, and has a Japanese national license as a pharmacist, since 1988. After working for a pharmaceutical company for thirteen years as a basic and clinical research scientist and a product manager, she went to the U.S.A. as a Fulbright scholar and studied genetic counseling at the joint graduate program of the National Human Genome Research Institute and Johns Hopkins University School of Public Health, and graduated in 2003 getting the master’s degree. She has been certified as a genetic counselor by the American Board of Genetic Counseling as well as the Japanese Board of Genetic Counseling. She is currently the only person who holds both American and Japanese certificates as a genetic counselor, and is now a board member of the Japanese Association of Certified Genetic Counselors. After returning to Japan in 2003, she worked as a genetic counselor, at many different medical institutions, including the Japan’s National Center for Child Health and Development, several university hospitals and major fertility clinics, covering a variety of conditions, including prenatal, pediatrics, adult genetics, cancer genetics, neurogenetics, and infertility, etc. Ms. Tamura also worked as an associate professor for five years at one of the newly established genetic counseling training graduate programs at Ochanomizu University in Tokyo. She has been working as an advisor to several patient and family support groups, with Marfan syndrome, Turner syndrome, prion diseases, familial colon cancer, spinocerebellar ataxia, etc.
■Date and Time
Sep 19, 2013 8:00am-9:00am
■Venue
GARB Marunouchi (2-2-3 Marunouchi, Chiyoda-ku, Tokyo)
Exhibition date:2013-09-19
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Public Comment Submission] The UN Special Rapporteur’s Call for Input on Protecting Clean Air (October 16, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)





